You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,001,861


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,001,861
Title: Use of pramipexole in the treatment of restless legs syndrome
Abstract:The present invention provides the use of pramipexole in the treatment of restless legs syndrome.
Inventor(s): Oertel; Wolfgang H. (Ranschenberg, DE), Meier; Dieter (Weisbaden, DE), Gomez-Mancilla; Baltazar (Portage, MI), Montplaisir; Jacques (Montreal, CA)
Assignee: Pharmacia & Upjohn Company (Kalamzoo, MI)
Application Number:09/008,212
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent claims and scope, using the context of U.S. patents, and will provide a detailed analysis of the patent landscape, particularly focusing on the elements that define a patent's boundaries and protections.

What are Patent Claims?

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and fully supported by the description in the patent specification[5].

Types of Claims

  • Independent Claims: These claims stand alone and do not rely on other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims refer back to and further limit an independent claim. They narrow down the scope of the invention and often add specific details or variations[5].

Measuring Patent Scope

The scope of a patent is a critical aspect that determines its breadth and the extent of protection it offers. Here are some metrics used to measure patent scope:

Independent Claim Length and Count

Research has shown that independent claim length and count are simple yet effective metrics for measuring patent scope. Patents with narrower claims, as indicated by shorter independent claim lengths and fewer independent claims, tend to have a higher probability of grant and a shorter examination process[3].

Patent Maintenance Payments and Forward Citations

Patents that require higher maintenance payments and receive more forward citations are often considered to have broader scope and greater impact. These metrics indicate the patent's relevance and influence in the field[3].

The Role of Patent Claims in the Examination Process

The examination process is where the patent claims are scrutinized to ensure they meet the statutory requirements for patentability.

Novelty and Non-Obviousness

Claims must be novel and non-obvious over the prior art. This means the invention must be new and not obvious to a person skilled in the art[1].

Adequate Description and Disclosure

The claims must be adequately described and disclosed so that another person skilled in the art can make and use the claimed invention[1].

Narrowing Claims During Examination

The examination process often results in the narrowing of patent claims. Broader claims at the time of publication may be narrowed down during the examination to ensure they meet the patentability criteria[3].

Follow-On Patents and Market Exclusivity

Follow-on patents, which involve innovations to an already patented drug or product, can significantly impact market exclusivity.

Examples from the Pharmaceutical Industry

A study by the USPTO and FDA identified examples of follow-on patents in the pharmaceutical industry, such as patents for once-daily dosage forms of a drug or new methods of use. These patents can extend market exclusivity beyond the expiration of the original patent if they meet the criteria for patentability[1].

Impact on Generic and Biosimilar Competition

The issuance of follow-on patents can delay the entry of generic or biosimilar products into the market, affecting competition and drug prices. This is a critical consideration in the context of public health and economic policy[1].

The Orange Book and Patent Exclusivity

The Orange Book, published by the FDA, compiles patent and exclusivity information for approved drug products. It plays a crucial role in understanding the interplay between patents and exclusivities.

Patent and Exclusivity Data

The Orange Book lists patents associated with drug products, including the patent filing and issue dates, patent expiration dates, and exclusivity data. This information is essential for determining when generic or biosimilar products can enter the market[1].

Case Study: Understanding Patent Claims Through an Example

To illustrate the concepts discussed, let's consider a hypothetical example similar to what might be found in the pharmaceutical industry.

Example: A New Dosage Form

Imagine a company has developed a new once-daily dosage form for an existing drug. The original drug had a patent that is about to expire. The company files a new patent application for the once-daily dosage form.

  • Independent Claim: "A pharmaceutical composition comprising [active ingredient] in a dosage form suitable for once-daily administration."
  • Dependent Claim: "The pharmaceutical composition of claim 1, wherein the dosage form is a tablet."

In this example, the independent claim defines the broad scope of the invention, while the dependent claim narrows it down to a specific form of the dosage.

Best Practices for Drafting Patent Claims

Drafting effective patent claims requires a deep understanding of the invention and the legal framework.

Clarity and Conciseness

Claims should be clear and concise to avoid ambiguity and ensure that the scope of the invention is well-defined[5].

Support from the Specification

The claims must be fully supported by the description in the patent specification. This ensures that the claims are not overly broad and are grounded in the disclosed invention[5].

The Importance of Terminal Disclaimers

Terminal disclaimers are used to ensure that multiple patents related to the same invention do not extend the duration of exclusivity.

Ensuring Common Ownership

When multiple patents are filed for different aspects of the same invention, a terminal disclaimer may be required to ensure that all patents expire on the same date, preventing the extension of exclusivity[1].

Conclusion

Understanding the scope and claims of a patent is essential for protecting intellectual property and navigating the complex landscape of innovation.

Key Takeaways

  • Patent Claims Define Invention Scope: Claims are the core of a patent application and must be clear, concise, and supported by the specification.
  • Metrics for Measuring Scope: Independent claim length and count, patent maintenance payments, and forward citations are key metrics.
  • Follow-On Patents: These can extend market exclusivity if they meet patentability criteria.
  • Orange Book: Provides critical information on patent and exclusivity data for drug products.
  • Best Practices: Clarity, conciseness, and support from the specification are crucial for effective claim drafting.

FAQs

Q: What is the purpose of independent and dependent claims in a patent application?

A: Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding specific details or variations.

Q: How do follow-on patents impact market exclusivity?

A: Follow-on patents can extend market exclusivity beyond the expiration of the original patent if they meet the criteria for patentability.

Q: What is the role of the Orange Book in patent and exclusivity data?

A: The Orange Book compiles patent and exclusivity information for approved drug products, helping to determine when generic or biosimilar products can enter the market.

Q: Why are terminal disclaimers important in patent law?

A: Terminal disclaimers ensure that multiple patents related to the same invention do not extend the duration of exclusivity by requiring them to expire on the same date.

Q: What metrics are used to measure the scope of a patent?

A: Metrics include independent claim length and count, patent maintenance payments, and forward citations.

Sources

  1. USPTO-FDA Report on Drug Patent and Exclusivity. USPTO, 2018.
  2. Patent Claims Research Dataset. USPTO, 2017.
  3. Patent Claims and Patent Scope. SSRN, 2016.
  4. Silver nanoparticle production method, silver nanoparticle, and .... PubChem.
  5. The Path to a Patent, Part V: Understanding the role of claims in a patent application. USPTO, 2024.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,001,861

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,001,861

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 281165 ⤷  Subscribe
Australia 6016898 ⤷  Subscribe
Australia 723119 ⤷  Subscribe
Bulgaria 103543 ⤷  Subscribe
Bulgaria 64614 ⤷  Subscribe
Canada 2275379 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.